Mirica® Advanced - Enhanced Absorption Formula - Palmitoylethanolamide (PEA) and Luteolin - 60 Capsules
Synergistic Combination of Palmitoylethanolamide (PEA) and Luteolin
Mirica® Advanced contains Levagen®+ PEA with Nearly Twice the Absorption of Standard PEA**
Safe, Effective, Non-Addictive Pain Reducer*
Over 800 published studies and Over 50 Clinical Trials support PEA’s anti-inflammatory, neuroprotective, immune supporting, analgesic properties*
Recommended by Doctors*
Increases Your Body’s Natural Pain Reducing Endocannabinoids*
All Young Nutraceuticals Products are manufactured in the USA under strict Good Manufacturing Practices (cGMP) set by the FDA and are produced with the highest quality ingredients and tested by 3rd party lab for purity and potency*
No artificial ingredients
Mirica® Advanced is made from the highest quality pharmaceutical-grade ingredients available. Mirica® Advanced is made with pure Levagen®+ PEA, clinically shown to have nearly twice the absorption of standard PEA. We believe purity matters, especially when a supplement is a daily part of your life. That's why we never compromise on our ingredients.
The palm oil used in Mirica's PEA is certified by the Roundtable on Sustainable Palm Oil. This ensures that:
- Valuable tropical forests were not cleared
- Social and environmental safeguards were met during harvest and production
Learn more at RSPO.org >>
What is PEA?
Palmitoylethanolamide (PEA) is a biologically active, endogenous lipid that is widely distributed throughout the body's tissues and is synthesized on demand. (Gabrielsson 2016) It was first isolated in 1957 as an anti-inflammatory component in egg yolks and is found in many foods. PEA has been studied extensively for its anti-inflammatory, neuroprotective and analgesic properties since the 1970's.* (Hesselink 2013)
PEA plays a key role in maintaining homeostasis by regulating many physiological reactions associated with pain and inflammation. Some chronic conditions can deplete PEA, resulting in a hyper-immune response involving glial, microglial and mast cells. Excessive activation of these satellite, non-neuronal cells has been shown to maintain inflammation and result in neurodegeneration. PEA reduces excessive activation of these cells and decreases neuron loss.* (Raso 2014)
In a recent meta-analysis of PEA involving a total of 1484 chronic pain patients, those taking PEA reported pain levels an average of 2.7 points lower than the control groups after 60 days.* (Paladini 2016)
What is Luteolin?
Luteolin is a potent bioflavonoid with antioxidant and anti-inflammatory properties. Like PEA, luteolin has several mechanisms of action. It inhibits mast cells, as well as mast cell-dependent T cell activation.* (Theoharides 2018) In addition, it modulates microglial activation and inhibits pro-inflammatory cytokine production. (Dirscherl 2010) It also acts on GABA and opioid receptors in the spinal cord.* (Li 2015)
The Synergistic Combination of PEA & Luteolin
When combined, PEA and luteolin show enhanced anti-inflammatory, anti-oxidant and neuroprotective properties. Coadministration of PEA with luteolin has been shown to decrease mast cell activation significantly more than PEA or luteolin alone. This combination has been shown to reduce pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6) and chemokines (MIP-1 alpha, MIP-2) significantly more than PEA or luteolin alone. Additionally, PEA with luteolin was shown to reduce oxidative and nitrosative damage more effectively than PEA or luteolin alone.* (Impellizzeri 2018)
Side Effect Free
PEA occurs naturally in the body and in many foods. No side effects have been reported with its use, even at the highest doses. (Gabrielsson 2016)
The recommended daily dose of Mirica® is equivalent to the amount of luteolin found in one artichoke. At this dose luteolin is safe and no side effects have been reported.
Mirica® is made in a cGMP registered, FDA registered facility in the USA and tested by an independent lab.
**A parallel, double-blind, bioavailability study to measure uptake of PEA over a 24-hour period found the Levagen+ formulation significantly increased plasma PEA concentration above baseline concentrations by approximately 1.8 times that of the standard PEA formulation.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.